Curis
CRIS
#10340
Rank
C$27.82 M
Marketcap
C$0.71
Share price
4.43%
Change (1 day)
-74.66%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.08. In 2024 the company made an earnings per share (EPS) of C-$9.72 an increase over its 2023 EPS that were of C-$12.49.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-46.53%
2024C-$9.72-22.15%
2023C-$12.49-26.17%
2022C-$16.9222.3%
2021C-$13.83-25.37%
2020C-$18.54-30.93%
2019C-$26.83-2.02%
2018C-$27.39
2016C-$62.25-10%
2015C-$69.16138.1%
2014C-$29.0540%
2013C-$20.75-25%
2012C-$27.6666.67%
2011C-$16.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.81-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.92-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.33-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.38 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.55 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.95-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA